Niels Kristian Klausen

Title: **Niels Kristian Klausen: Innovator in Glycoprotein Research**

Introduction

Niels Kristian Klausen, an accomplished inventor hailing from Gentofte, Denmark, has made significant contributions to the field of glycoprotein research. With a total of three patents to his name, Klausen is recognized for his innovative approaches to understanding and manipulating the glycosylation processes of polypeptides, which have important implications in medical and pharmaceutical applications.

Latest Patents

Klausen's latest patents showcase his expertise in glycoproteins. One of his notable inventions is titled "O-linked glycoforms of polypeptides and method to manufacture them." This patent pertains to compositions that contain glycoproteins exhibiting altered patterns of O-linked glycosylation, specifically targeting Factor VII and Factor IX. The methods outlined in this patent provide a new approach for producing these important glycoproteins.

Another significant patent, "Pegylated factor VII glycoforms," focuses on the formulation of a preparation comprising multiple Factor VII polypeptides or related polypeptides. In this invention, the polypeptides include asparagine-linked and/or serine-linked oligosaccharide chains, with at least one oligosaccharide group being covalently bonded to a polymeric group. These innovations represent critical advancements in the production of glycoproteins that could enhance therapeutic applications.

Career Highlights

Throughout his career, Klausen has worked with leading organizations in the healthcare sector, including Novo Nordisk Healthcare AG and Novo Nordisk Health Care A/S. His affiliation with these esteemed companies underscores his commitment to advancing medical science and his involvement in significant research initiatives that prioritize health and innovation.

Collaborations

Klausen has also collaborated with notable professionals in his field, including Hans Kurt Pingel and Søren Erik Bjorn. These partnerships have likely enhanced his research capabilities and contributed to the success of his innovative projects, pushing the boundaries of what is possible within glycoprotein research.

Conclusion

Niels Kristian Klausen stands out as a prominent inventor in the landscape of glycoprotein research. His patents and collaborations demonstrate a profound commitment to innovation, potentially leading to breakthroughs in medical treatments. As research continues to evolve, Klausen's contributions will likely play a crucial role in the advancement of therapeutic strategies involving glycoproteins.